COVID-19 Impact on the Global Bioreactors Market
- Get link
- Other Apps
A bioreactor is a vessel that has been constructed or manufactured for the production of a wide range of biological products. A biochemical process is carried out in an industrial bioreactor employing microorganisms and animal cells, or biologically active chemicals produced from living cells. The most significant component in bioprocessing is the bioreactor, which is cylindrical in shape and has a capacity ranging from litres to cubic metres.
Bioreactors
are used in fermentation processes such as wine and beer manufacture. Stainless
steel is used in bioreactors
Market and for large-scale manufacturing of medicinal goods. Small
glass bioreactors are utilised in biopharmaceutical firms for research and
development as well as scale-up activities.
Bioreactors Market |
COVID-19 is
a newly identified novel coronavirus that causes an infectious sickness.
COVID-19, which was mostly unknown until the outbreak in Wuhan, China, in
December 2019, has gone from a regional issue to a global pandemic in just a
few weeks. On March 11, 2020, the World Health Organization (WHO) proclaimed
COVID-19 a pandemic. In response to the novel coronavirus pandemic, many
biopharmaceutical companies are swiftly developing vaccines.
Moderna
Therapeutics, for example, is testing a messenger RNA vaccine in Phase I trials,
Inovio Pharmaceuticals is testing a DNA vaccine in humans, and Novavax is
working on a vaccine based on its recombinant protein nanoparticle platform.If
these programmes pass their trials, single-use equipment and systems will be
used to support clinical and commercial manufacturing platforms. In the quest
to produce a vaccination against the coronavirus, many prominent single-use bioreactor
manufacturers are presently collaborating with firms that are
developing or testing a vaccine. Sartorius, for example, has aided CanSino
Biologics Inc. and Maj. Gen. Chen Wei's team at China's Academy of Military
Medical Sciences' Institute of Bioengineering in the creation of the first
vaccine candidate against the new coronavirus SARS-CoV-2 to enter clinical
trials. In some ways, this has had a good effect on the SUB market.
- Get link
- Other Apps
Comments
Post a Comment